- Company: Perceptec (Startup from Jena)
- Funding amount: 930,000 euros
- Project goal: Automated determination of visual impairments
- Technology: Innovative 3D display technology
- Planned market launch: 2027
JENA (17.02.2026) – Once again, Jena proves its reputation as a center for optics and photonics. The local startup Perceptec has secured significant funding to fundamentally change the way we have our eyes tested. With nearly one million euros in funding, a new process is to be brought to market maturity.
Research Funding for the Ophthalmology of the Future
According to current reports, the Jena-based startup Perceptec has been awarded funding totaling 930,000 euros. These funds will flow into an ambitious research project dedicated to the automated determination of visual impairments. In a city that virtually invented modern optics through Ernst Abbe and Carl Zeiss, this development fits seamlessly into the tradition of technical innovation.
The core of the innovation is a special 3D display technology. Unlike traditional eye tests, which often still require mechanical lens boxes and subjective queries by staff, the Jena-based company relies on digital precision. The goal is ambitious: by the year 2027, a fully market-ready medical product is to be created for use in doctor’s offices and potentially also at opticians.
Relief for the Healthcare System
The relevance of this project goes beyond the purely technical aspect. Conventional eye tests to determine refraction (the refractive power of the eye) are labor-intensive and time-consuming. In times of specialist shortages and crowded waiting rooms at ophthalmologists, automation offers enormous advantages.
Through the new technology, routine examinations could be carried out faster in the future and without constant supervision by highly specialized personnel. This would leave doctors more time for complex diagnoses and treatments. Furthermore, the company indicates that the technology could also be used mobilely. This would be a major step for telemedical care, for example in rural regions of Thüringen, where the path to the nearest specialist is often long.
Outlook: The Path to Market Maturity
With the secured funding, Perceptec can now initiate the next phase of development. The coming months and years will show how the technology proves itself in practical tests. If the schedule is met, a device from Jena could be in practices worldwide as early as 2027, making eye tests more efficient and accessible.
For the business location Jena, this is another signal of the vitality of the local startup scene, particularly in the fields of medical technology and optics.
Sources:
Original
Transparency note: This article was automatically created, editorially reviewed, and expanded with AI support.